Annual Total Liabilities
$27.23 M
+$13.80 M+102.69%
December 31, 2023
Summary
- As of February 26, 2025, CLRB annual total liabilities is $27.23 million, with the most recent change of +$13.80 million (+102.69%) on December 31, 2023.
- During the last 3 years, CLRB annual total liabilities has risen by +$23.37 million (+604.68%).
- CLRB annual total liabilities is now -23.98% below its all-time high of $35.83 million, reached on December 31, 2009.
Performance
CLRB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$22.13 M
+$5.12 M+30.14%
September 30, 2024
Summary
- As of February 26, 2025, CLRB quarterly total liabilities is $22.13 million, with the most recent change of +$5.12 million (+30.14%) on September 30, 2024.
- Over the past year, CLRB quarterly total liabilities has stayed the same.
- CLRB quarterly total liabilities is now -38.24% below its all-time high of $35.83 million, reached on December 31, 2009.
Performance
CLRB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CLRB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.7% | 0.0% |
| 3 y3 years | +604.7% | +557.0% |
| 5 y5 years | +1418.8% | +545.6% |
CLRB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +555.2% | -36.6% | +432.4% |
| 5 y | 5-year | at high | +753.4% | -36.6% | +593.4% |
| alltime | all time | -24.0% | >+9999.0% | -38.2% | >+9999.0% |
Cellectar Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.13 M(+30.1%) |
| Jun 2024 | - | $17.00 M(+1.6%) |
| Mar 2024 | - | $16.74 M(-38.5%) |
| Dec 2023 | $27.23 M(+102.7%) | $27.23 M(-22.0%) |
| Sep 2023 | - | $34.90 M(+400.3%) |
| Jun 2023 | - | $6.98 M(-7.0%) |
| Mar 2023 | - | $7.50 M(-44.2%) |
| Dec 2022 | $13.44 M(+223.2%) | $13.44 M(+104.5%) |
| Sep 2022 | - | $6.57 M(+15.3%) |
| Jun 2022 | - | $5.70 M(+19.2%) |
| Mar 2022 | - | $4.78 M(+15.0%) |
| Dec 2021 | $4.16 M(+7.6%) | $4.16 M(+23.4%) |
| Sep 2021 | - | $3.37 M(-10.3%) |
| Jun 2021 | - | $3.75 M(-29.0%) |
| Mar 2021 | - | $5.29 M(+36.8%) |
| Dec 2020 | $3.86 M(+21.1%) | $3.86 M(-13.6%) |
| Sep 2020 | - | $4.47 M(+15.7%) |
| Jun 2020 | - | $3.87 M(+12.3%) |
| Mar 2020 | - | $3.44 M(+7.9%) |
| Dec 2019 | $3.19 M(+78.0%) | $3.19 M(-6.9%) |
| Sep 2019 | - | $3.43 M(+8.8%) |
| Jun 2019 | - | $3.15 M(+16.6%) |
| Mar 2019 | - | $2.70 M(+50.7%) |
| Dec 2018 | $1.79 M(-15.3%) | $1.79 M(-32.6%) |
| Sep 2018 | - | $2.66 M(+16.2%) |
| Jun 2018 | - | $2.29 M(+8.6%) |
| Mar 2018 | - | $2.11 M(-0.4%) |
| Dec 2017 | $2.12 M(+18.6%) | $2.12 M(-7.1%) |
| Sep 2017 | - | $2.28 M(+31.2%) |
| Jun 2017 | - | $1.74 M(+12.2%) |
| Mar 2017 | - | $1.55 M(-13.2%) |
| Dec 2016 | $1.78 M(-70.0%) | $1.78 M(+13.0%) |
| Sep 2016 | - | $1.58 M(+2.0%) |
| Jun 2016 | - | $1.55 M(-48.3%) |
| Mar 2016 | - | $2.99 M(-49.7%) |
| Dec 2015 | $5.95 M(-11.5%) | $5.95 M(+2.9%) |
| Sep 2015 | - | $5.78 M(-6.9%) |
| Jun 2015 | - | $6.21 M(-1.8%) |
| Mar 2015 | - | $6.32 M(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $6.72 M(+31.4%) | $6.72 M(+161.5%) |
| Sep 2014 | - | $2.57 M(-69.5%) |
| Jun 2014 | - | $8.43 M(-3.9%) |
| Mar 2014 | - | $8.77 M(+71.4%) |
| Dec 2013 | $5.12 M(+287.7%) | $5.12 M(-2.0%) |
| Sep 2013 | - | $5.22 M(-21.9%) |
| Jun 2013 | - | $6.68 M(-7.0%) |
| Mar 2013 | - | $7.18 M(+444.1%) |
| Dec 2012 | $1.32 M(+22.0%) | $1.32 M(-0.2%) |
| Sep 2012 | - | $1.32 M(+8.5%) |
| Jun 2012 | - | $1.22 M(+12.1%) |
| Mar 2012 | - | $1.09 M(+0.5%) |
| Dec 2011 | $1.08 M(-76.8%) | $1.08 M(-1.4%) |
| Sep 2011 | - | $1.10 M(+7.3%) |
| Jun 2011 | - | $1.02 M(+27.2%) |
| Mar 2011 | - | $804.40 K(-82.8%) |
| Dec 2010 | $4.67 M(-87.0%) | $4.67 M(-77.2%) |
| Sep 2010 | - | $20.51 M(+4.6%) |
| Jun 2010 | - | $19.60 M(-2.1%) |
| Mar 2010 | - | $20.03 M(-44.1%) |
| Dec 2009 | $35.83 M(+71.0%) | $35.83 M(+27.1%) |
| Sep 2009 | - | $28.20 M(-6.0%) |
| Jun 2009 | - | $29.99 M(+458.7%) |
| Mar 2009 | - | $5.37 M(-74.4%) |
| Dec 2008 | $20.95 M(+23.4%) | $20.95 M(-1.7%) |
| Sep 2008 | - | $21.31 M(-5.7%) |
| Jun 2008 | - | $22.59 M(+13.0%) |
| Mar 2008 | - | $20.00 M(+17.8%) |
| Dec 2007 | $16.98 M(+1192.7%) | $16.98 M(+257.2%) |
| Sep 2007 | - | $4.75 M(-63.0%) |
| Jun 2007 | - | $12.84 M(+881.9%) |
| Mar 2007 | - | $1.31 M(-0.5%) |
| Dec 2006 | $1.31 M(+504.7%) | $1.31 M(+18.6%) |
| Sep 2006 | - | $1.11 M(+74.3%) |
| Jun 2006 | - | $635.40 K(+33.6%) |
| Mar 2006 | - | $475.60 K(+119.0%) |
| Dec 2005 | $217.20 K | $217.20 K(-68.8%) |
| Sep 2005 | - | $695.60 K(-19.6%) |
| Jun 2005 | - | $864.70 K(+656.5%) |
| Mar 2005 | - | $114.30 K |
FAQ
- What is Cellectar Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Cellectar Biosciences?
- What is Cellectar Biosciences annual total liabilities year-on-year change?
- What is Cellectar Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly total liabilities year-on-year change?
What is Cellectar Biosciences annual total liabilities?
The current annual total liabilities of CLRB is $27.23 M
What is the all time high annual total liabilities for Cellectar Biosciences?
Cellectar Biosciences all-time high annual total liabilities is $35.83 M
What is Cellectar Biosciences annual total liabilities year-on-year change?
Over the past year, CLRB annual total liabilities has changed by +$13.80 M (+102.69%)
What is Cellectar Biosciences quarterly total liabilities?
The current quarterly total liabilities of CLRB is $22.13 M
What is the all time high quarterly total liabilities for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly total liabilities is $35.83 M
What is Cellectar Biosciences quarterly total liabilities year-on-year change?
Over the past year, CLRB quarterly total liabilities has changed by $0.00 (0.00%)